NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 25, 2025 — Cancer Support Community SF Bay Area breaks ground on new cancer support center in Lafayette, CA as part of 'Rooted in Resilience' Capital Campaign. Key figures like Mayor of Lafayette and Congressman Mark DeSaulnier attend event to show support for comprehensive cancer care programs.
April 24, 2025 — GeoVax Labs responds to the detection of Clade I Mpox viral particles in North Carolina, emphasizing the need for expanded preparedness and vaccine availability. Learn how the company's GEO-MVA vaccine is advancing as a key U.S.-developed candidate for Mpox/smallpox.
April 24, 2025 — Utah Healthcare Innovation Network partners with local organizations to accelerate healthcare startups and drive innovation in the industry. Learn how this initiative is set to improve healthcare accessibility, affordability, and quality in Utah.
April 24, 2025 — Helix BioPharma Corp. announces the appointment of Veronika Kandziora as COO and Jessica Kourniaktis as Director of Communications to drive growth and advance the fight against hard-to-treat cancers. Learn more about the strategic moves and key players at Helix.
April 24, 2025 — InnerScope (OTC: INND) officially opens OTCHealthMart.com, a platform offering a variety of OTC health products. CEO Matthew Moore expresses commitment to affordable healthcare solutions and plans to expand offerings to include durable medical equipment.
April 24, 2025 — InnerScope launches OTCHealthMart.com, a platform offering OTC health and wellness products. The move aims to improve healthcare accessibility and affordability for consumers, including the 55+ demographic.
April 24, 2025 — Discover how NAVEX One is transforming HIPAA compliance for healthcare organizations with centralized policy management, employee training, and risk assessment solutions. Learn how this platform streamlines compliance efforts, enhances privacy and security programs, and helps organizations meet regulatory requirements.
April 24, 2025 — NAVEX introduces NAVEX One, a platform offering centralized policy management, employee training, and risk assessment solutions aligned with HIPAA for healthcare organizations. Learn how NAVEX is streamlining HIPAA compliance, reducing administrative burden, and supporting a proactive approach to privacy and risk management.
April 24, 2025 — GeoVax Labs presents successful clinical data on GEO-CM04S1 vaccine at World Vaccine Congress, highlighting robust immune responses in healthy and immunocompromised populations. The dual-antigen approach demonstrates durable T cell and antibody responses, positioning the vaccine as a promising solution for COVID-19 protection.
April 24, 2025 — NeuroSense Therapeutics is on the verge of a groundbreaking pharmaceutical partnership for its ALS therapy, PrimeC, showcasing a 58% survival improvement. The nearing deal could fully fund the upcoming Phase 3 trial, marking a significant milestone for the company in the neurodegenerative disease market.
April 24, 2025 — NeuroSense Therapeutics is on the verge of a potential blockbuster pharma deal as their ALS drug shows a 58% survival improvement. Stay tuned for updates on this transformative partnership and the promising PrimeC therapy.
April 24, 2025 — Soligenix announces positive results for HyBryte™ skin cancer treatment, with 75% of patients showing improvement in CTCL after 18 weeks. The treatment offers a faster and safer alternative, potentially revolutionizing the standard of care for this rare disease.
April 24, 2025 — Saudi Arabia's adoption of AI and telemedicine for healthcare reflects a global trend towards technological integration. Learn how this move is set to revolutionize healthcare accessibility and quality.
April 24, 2025 — Learn how stem cell therapy is transforming the landscape of blood cancer treatment, offering new hope and potential cures for leukemia, myeloma, and lymphoma patients. Discover the innovative research by Calidi Biotherapeutics Inc. in developing cutting-edge stem cell solutions for various types of cancer.
April 24, 2025 — Discover how stem cell therapy is transforming the landscape of blood cancer treatment and providing hope for leukemia, myeloma, and lymphoma patients. Learn more about the innovative work of Calidi Biotherapeutics Inc. in advancing this life-saving treatment.
April 24, 2025 — Saudi Arabia utilizes AI and telemedicine to revolutionize healthcare under Vision 2030. D-Wave Quantum Inc. (NYSE: QBTS) stands to gain from the AI trend.
April 24, 2025 — Quantum BioPharma appoints Kevin Malone as advisor, emphasizing shareholder protection values and therapeutic focus. Malone brings expertise in wealth management and market pattern recognition, aligning with the company's mission against trading manipulation. Company focuses on innovative solutions for neurodegenerative disorders, such as Lucid-MS, a compound targeting multiple sclerosis.
April 24, 2025 — Quantum BioPharma appoints Kevin Malone as an advisor to its Board of Directors, showcasing a strategic move for growth and innovation in the biopharmaceutical sector. Malone's financial expertise and advocacy against trading manipulation align with Quantum's values, emphasizing shareholder protection and therapeutic focus.
April 24, 2025 — Tonix Pharmaceuticals presents positive preclinical data on TNX-801 vaccine at World Vaccine Congress, demonstrating efficacy against mpox and rabbitpox. The vaccine aligns with WHO standards, offering potential for broad application in global health emergencies.
April 24, 2025 — Tonix Pharmaceuticals presents promising results for TNX-801 vaccine at World Vaccine Congress, demonstrating efficacy against mpox and rabbitpox with lasting protection. Learn more about the company's innovative solutions.